For instance, breast cancer–initiating cells were eliminated in vitro and in vivo when Wnt/β-catenin signaling was inhibited with small molecule antagonist (25), and β-catenin inhibition sensitized PIK3CA-mutant breast cancer to PI3K inhibitors (26). The gene discussed is PIK3CA; the disease is breast carcinoma.